<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>BiG生物创新社 | wechat-feeds</title><link>http://MzkxNTA5NjM1OA.favicon.privacyhide.com/favicon.ico</link><description>BiG, Biologics Innovation Group. To nurture an Eco-system for Biologics innovation and imprint China on Global map.</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 16 Jun 2021 17:18:24 +0800</pubDate><image><url>http://MzkxNTA5NjM1OA.favicon.privacyhide.com/favicon.ico</url><title>BiG生物创新社 | wechat-feeds</title><link>http://MzkxNTA5NjM1OA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>再生元｜PD-1+CD28 X TSA 双抗，能持久抗瘤么？</title><link>https://mp.weixin.qq.com/s/nNOO1tEEHl58MzQSiyaBcw</link><description></description><content:encoded><![CDATA[再生元｜PD-1+CD28 X TSA 双抗，能持久抗瘤么？]]></content:encoded><pubDate>Wed, 16 Jun 2021 16:22:11 +0800</pubDate></item><item><title>新江湖 | 蓝西实验室加入BiG会员机构！</title><link>https://mp.weixin.qq.com/s/Bvy-ZlXiQ051QTRsmQpSgA</link><description></description><content:encoded><![CDATA[新江湖 | 蓝西实验室加入BiG会员机构！]]></content:encoded><pubDate>Wed, 16 Jun 2021 16:22:11 +0800</pubDate></item><item><title>五种溶瘤病毒的升级武装策略！</title><link>https://mp.weixin.qq.com/s/TMmQpRoyuMuOxQzbOgMaDg</link><description></description><content:encoded><![CDATA[五种溶瘤病毒的升级武装策略！]]></content:encoded><pubDate>Tue, 15 Jun 2021 16:19:01 +0800</pubDate></item><item><title>T-DXd: HER-2+实体瘤治疗的变革者</title><link>https://mp.weixin.qq.com/s/_vX7YDCV4wD8FqqsQvXgCA</link><description></description><content:encoded><![CDATA[T-DXd: HER-2+实体瘤治疗的变革者]]></content:encoded><pubDate>Tue, 15 Jun 2021 16:19:01 +0800</pubDate></item><item><title>RNA 靶向药物｜设计策略与生产工艺优化</title><link>https://mp.weixin.qq.com/s/Opm3ttr4bI2Tw6wxAWQ34Q</link><description></description><content:encoded><![CDATA[RNA 靶向药物｜设计策略与生产工艺优化]]></content:encoded><pubDate>Mon, 14 Jun 2021 10:30:01 +0800</pubDate></item><item><title>​不止mRNA，六种肿瘤疫苗及其优缺点</title><link>https://mp.weixin.qq.com/s/qvzSbHrn2VVvuEruAkLPOg</link><description></description><content:encoded><![CDATA[​不止mRNA，六种肿瘤疫苗及其优缺点]]></content:encoded><pubDate>Mon, 14 Jun 2021 10:30:01 +0800</pubDate></item><item><title>非典型T细胞三剑客：NKT、MAIT、γδT</title><link>https://mp.weixin.qq.com/s/1ukbjKA1CR6VzWfyEYQbWg</link><description></description><content:encoded><![CDATA[非典型T细胞三剑客：NKT、MAIT、γδT]]></content:encoded><pubDate>Fri, 11 Jun 2021 17:31:28 +0800</pubDate></item><item><title>新江湖 | 上海临港经济发展集团加入BiG会员机构！</title><link>https://mp.weixin.qq.com/s/msGJMiz38BahrwDmPlzskQ</link><description></description><content:encoded><![CDATA[新江湖 | 上海临港经济发展集团加入BiG会员机构！]]></content:encoded><pubDate>Fri, 11 Jun 2021 17:31:28 +0800</pubDate></item><item><title>RNA靶向药物｜浪潮巨幕，群雄诸起！</title><link>https://mp.weixin.qq.com/s/P2bUGcDZOq3PEZTOYlfd3Q</link><description></description><content:encoded><![CDATA[RNA靶向药物｜浪潮巨幕，群雄诸起！]]></content:encoded><pubDate>Fri, 11 Jun 2021 15:26:40 +0800</pubDate></item><item><title>开发First-in-class新药！Immune-Onc于杭州生物科技谷开业</title><link>https://mp.weixin.qq.com/s/oX8XfKp5JhucNIKRqBnK_Q</link><description></description><content:encoded><![CDATA[开发First-in-class新药！Immune-Onc于杭州生物科技谷开业]]></content:encoded><pubDate>Fri, 11 Jun 2021 15:26:40 +0800</pubDate></item><item><title>​从KRAS G12C们的内卷，看中国新药研发的焦虑！</title><link>https://mp.weixin.qq.com/s/ck5ndKAiUd73BARv6NL6Bw</link><description></description><content:encoded><![CDATA[​从KRAS G12C们的内卷，看中国新药研发的焦虑！]]></content:encoded><pubDate>Thu, 10 Jun 2021 17:51:49 +0800</pubDate></item><item><title>多面型选手，调节性B细胞-Breg</title><link>https://mp.weixin.qq.com/s/FAdtDttl5B9Wnn_kHBVpiw</link><description></description><content:encoded><![CDATA[多面型选手，调节性B细胞-Breg]]></content:encoded><pubDate>Thu, 10 Jun 2021 17:51:49 +0800</pubDate></item><item><title>破纪录｜20位新药研发/服务机构负责人加入BiG！</title><link>https://mp.weixin.qq.com/s/gAbKjF7vnCEBTeYaR5DncQ</link><description></description><content:encoded><![CDATA[破纪录｜20位新药研发/服务机构负责人加入BiG！]]></content:encoded><pubDate>Wed, 09 Jun 2021 14:42:00 +0800</pubDate></item><item><title>荐*会议 | SAPA2021中国年会即将隆重开幕！</title><link>https://mp.weixin.qq.com/s/4-dkjiMLqk7waJHPQg7xbw</link><description></description><content:encoded><![CDATA[荐*会议 | SAPA2021中国年会即将隆重开幕！]]></content:encoded><pubDate>Wed, 09 Jun 2021 14:42:00 +0800</pubDate></item><item><title>从信达引进Taletrectinib，看ROS1/NTRK靶点竞争</title><link>https://mp.weixin.qq.com/s/zMuJj2BXn0XoQv8xQkDAMw</link><description></description><content:encoded><![CDATA[从信达引进Taletrectinib，看ROS1/NTRK靶点竞争]]></content:encoded><pubDate>Wed, 09 Jun 2021 14:42:00 +0800</pubDate></item><item><title>渤健新药满城风雨，靶向TREM2会是AD新希望么？</title><link>https://mp.weixin.qq.com/s/rfjtN1j9_cAOMrVzm3A4Qg</link><description></description><content:encoded><![CDATA[渤健新药满城风雨，靶向TREM2会是AD新希望么？]]></content:encoded><pubDate>Tue, 08 Jun 2021 14:24:23 +0800</pubDate></item><item><title>FDA批准AD新药Aduhelm，会是饮鸠止渴么？</title><link>https://mp.weixin.qq.com/s/5dfVOaUpIt8IeUXosEjkaA</link><description></description><content:encoded><![CDATA[FDA批准AD新药Aduhelm，会是饮鸠止渴么？]]></content:encoded><pubDate>Tue, 08 Jun 2021 14:24:23 +0800</pubDate></item><item><title>对话80后创新者｜未来3-5年，AI制药界的最大突破？</title><link>https://mp.weixin.qq.com/s/Ery9jLraEl0EEkp5VbDZNA</link><description></description><content:encoded><![CDATA[对话80后创新者｜未来3-5年，AI制药界的最大突破？]]></content:encoded><pubDate>Mon, 07 Jun 2021 17:44:56 +0800</pubDate></item><item><title>如何提高ADC药物的实体瘤穿透性？</title><link>https://mp.weixin.qq.com/s/d4-Vwcr37-eVi2xqJlU-bg</link><description></description><content:encoded><![CDATA[如何提高ADC药物的实体瘤穿透性？]]></content:encoded><pubDate>Mon, 07 Jun 2021 17:44:56 +0800</pubDate></item><item><title>唇枪舌战！八位药企掌舵人激辩Biotech2.0</title><link>https://mp.weixin.qq.com/s/X73k5gifn1eEm_R5pXnB_Q</link><description></description><content:encoded><![CDATA[唇枪舌战！八位药企掌舵人激辩Biotech2.0]]></content:encoded><pubDate>Fri, 04 Jun 2021 22:25:18 +0800</pubDate></item></channel></rss>